Des-N-(methoxycarbonyl)-L-tert-leucine Bis-Boc Atazanavir
|
|
|
- CAS-Nr.
- 198904-86-8
- Englisch Name:
- Des-N-(methoxycarbonyl)-L-tert-leucine Bis-Boc Atazanavir
- Synonyma:
- -2-(4-(pyridin-2-yl);tert-Butyl 2-((2S,3S);Atazanavir Impurity 16;-2-hydroxy-4-phenylbutyl);Atazanavir Intermediate 4;Azanavir sulfate impurity 1;Atazanavir Sulfate Impurity J;Atazanavir Sulfate EP Impurity J;AtazanavirSulfateInterMediates-01;dimethylethoxy)carbonyl]amino]-2-hydroxy-4-
- CBNumber:
- CB21565542
- Summenformel:
- C32H42N4O5
- Molgewicht:
- 562.7
- MOL-Datei:
- 198904-86-8.mol
|
Des-N-(methoxycarbonyl)-L-tert-leucine Bis-Boc Atazanavir Eigenschaften
- Schmelzpunkt:
- 185-186℃
- Dichte
- 1.157
- Dampfdruck
- 0-0Pa at 25℃
- storage temp.
- Refrigerator
- Löslichkeit
- Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
- pka
- 10.05±0.50(Predicted)
- Aggregatzustand
- Solid
- Farbe
- Off-White to Pale Beige
- LogP
- 3.9 at 30℃ and pH6.9
- CAS Datenbank
- 198904-86-8
Sicherheit
- Risiko- und Sicherheitserklärung
- Gefahreninformationscode (GHS)
Des-N-(methoxycarbonyl)-L-tert-leucine Bis-Boc Atazanavir Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
White Solid
Verwenden
Des-N-(methoxycarbonyl)-L-tert-leucine Bis-Boc Atazanavir is an intermediate for the synthesis of Atazanavir (A790051) and the preparation of some peptide analogs.
Des-N-(methoxycarbonyl)-L-tert-leucine Bis-Boc Atazanavir Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Carbamic acid, [(1S,2S)-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-[(methylsulfonyl)oxy]-1-(phenylmethyl)propyl]-, 1,1-dimethylethyl ester (9CI)
TERT-BUTYL [(1S,2S)-1-BENZYL-2,3-DIHYDROXYPROPYL]CARBAMATE
198905-10-1
198905-08-7
(2R,3S)-3-(tert-Butoxycarbonyl)amino-1,2-epoxy-4-phenylbutane
tert-Butyl 2-(4-(pyridin-2-yl)benzyl)hydrazinecarboxylate
tert-Butyl [[4-(2-pyridinyl)phenyl]methylene]hydrazinecarboxylate
N-Boc-L-phenylalaninal
HYDRAZINECARBOXYLIC ACID, [[4-(2-PYRIDINYL)PHENYL]METHYLENE]-, 1,1-DIMETHYLETHYL ESTER
4-(2-Pyridinyl)benzaldehyde
4-BROMOBENZALDEHYDE DIMETHYL ACETAL
2-Brompyridin
4-Formylphenylboronic acid
tert-Butylcarbazat
Downstream Produkte
Des-N-(methoxycarbonyl)-L-tert-leucine Bis-Boc Atazanavir Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 123)Lieferanten
- -2-(4-(pyridin-2-yl)
- -2-hydroxy-4-phenylbutyl)
- tert-Butyl 2-((2S,3S)
- 2-[(2S,3S)-3-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-hydroxy-4-phenylbutyl] -2-[[4-(2-pyridiny
- 1-[4-(pyridin-2-yl)phenyl]-5(S)-2,5-bis[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-phenyl-2-azahexane
- 2-[(2S,3S)-3-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-hydroxy-4-phenylbutyl] -2-[[4-(2-pyridinyl)phenyl]methyl]hydrazinecarboxylic Acid 1,1-Dimethylethyl Ester
- Des-N-(methoxycarbonyl)-L-tert-leucine Bis-Boc Atazanavir
- dimethylethoxy)carbonyl]amino]-2-hydroxy-4-
- Hydrazinecarboxylic acid, 2-[(2S,3S)-3-[[(1,1-
- phenylbutyl]-2-[[4-(2-pyridinyl)phenyl]methyl]-,1,1-dimethylethyl ester
- Hydrazinecarboxylic acid, 2-[(2S,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-4-phenylbutyl]-2-[[4-(2-pyridinyl)phenyl]methyl]-, 1,1-dimethylethyl ester
- 1-[4-(Pyridin-2-yl)phenyl]-5(S)-2,5-bis[(tert-butyloxycarbonyl)-amino]-4(S)-hydroxyl-6-phenyl-2-azahexane
- 2-[(2S,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-4-phenylbutyl]-2-[[4-(2-pyridi
- 2-[(2S,3S)-3-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-hydroxy-4-phenylbutyl]-2-[[4-(2-pyridinyl)phenyl]methyl]hydrazinecarboxylic acid tert-butyl ester
- Tert-butyl 2-{(2S,3S)-3-[(tert-butoxycarbonyl)aMino]-2-hydroxy-4-phenylbutyl}-2-[4-(2-pyridinyl)benzyl]hydrazinecarboxylate
- 1-(4-(pyridin-2-yl)phenyl)-5(S)-2,5-bis((tert-butyloxy-carbonyl)
- AtazanavirSulfateInterMediates-01
- tert-Butyl 2-((2S,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-4-phenylbutyl)-2-(4-(pyridin-2-yl)benzyl)hydrazinecarboxylate
- Atazanavir Impurity 16
- Atazanavir EP Impurity J (Atazanavir Di-tert-butyl Analog)
- 2-[(2S,3S)-3-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-hydroxy-4-phenylbutyl]-2-
- 1-[4-(Pyridin-2Yl)Phenyl]-5(S)-2,5-Bis[Tert-Butyloxycarbonyl)Amino]-4(S)-Hydroxyl-6-Phenyl-2-Azhexane
- tert-Butyl 2-[(2S,3S)-3-(tert-butoxyformamido)-2-hydroxy-4-phenylbutyl]-2-[[4-(pyridin-2-yl)phenyl]methyl]hydrazine-1-carboxylate
- Des-N-(methoxycarbonyl)-L-tert-leucine Bis-Boc Atazanavir ISO 9001：2015 REACH
- tert-Butyl 2-[(2S,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-4-phenylbutyl]-2-[[4-(pyridin-2-
yl)phenyl]methyl]hydrazine-1-carboxylate
- 2-[(2S,3S)-3-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-hydroxy-4-phenyl-butyl]-2-[[4-(2-pyridinyl)phenyl]methyl]hydrazinecarboxyli
- Atazanavir Intermediate 4
- Atazanavir Sulfate Impurity J
- Atazanavir Sulfate EP Impurity J
- tert-Butyl 2-((2S,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-4-phenylbutyl)-2-(4-(pyridin-2-yl)benzyl)hydrazinecarboxylate (Atazanavir Impurity)
- Azanavir sulfate impurity 1
- 1-[4-(Pyridin-2-yl)phenyl]-5-(s)-2,5-bis[(tert-butylox ycarbonyl)-amino]-4(s)-hydroxyl-6-phenyl-2-azahex
- 198904-86-8
- 98904-86-8
- C32H42N4O5
- Aromatics Compounds
- Aromatics
- Chiral Reagents
- Heterocycles
